BioXtreme

Stroke Rehabilitation Robotics

Health Tech & Life Sciences
Active
Seed Petah Tikva, Israel Founded 2010
Last updated 2026-06-18
Total raised
$5.7M
Last: Grant 2024-03
Stage
Seed
Founded
2010
Headcount
13
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

BioXtreme is developing robotics systems to assist in patient rehabilitation from strokes, traumatic brain injuries, and other neurological disorders.

The compan'ys DeXtreme system integrates biofeedback and 3D virtual reality into real-life environments. The system uses precise measurements of muscle strength, range of motion, and other clinical scales to calculate and apply forces with high accuracy across the entire motion cycle. plaXtreme is an advanced robotic device designed to restore palm and finger motor skills in individuals who have experienced stroke, traumatic brain injuries, and other neurological conditions.

Patient progress is recorded and saved on the easy-to-use learning system, which is user-friendly, mobile, and secured. The system is designed to reduce existing rehabilitation treatment times by 50%.

Funding history · 4 rounds · $5.7M total

Q&A

What is BioXtreme's primary focus?
BioXtreme specializes in developing robotics systems to aid in patient rehabilitation from strokes, traumatic brain injuries, and other neurological disorders.
What is the total amount of funding BioXtreme has raised to date?
BioXtreme has raised a total of $5,666,000 in funding.
When was BioXtreme founded?
BioXtreme was founded in April 2010.
What is BioXtreme's employee count?
BioXtreme has 11-50 employees.
What is the DeXtreme system?
The DeXtreme system by BioXtreme integrates biofeedback and 3D virtual reality into real-life environments for rehabilitation, using precise measurements to apply forces accurately across the motion cycle.
What is the plaXtreme system?
The plaXtreme system is an advanced robotic device developed by BioXtreme to restore palm and finger motor skills in individuals recovering from stroke, traumatic brain injuries, and other neurological conditions.
When was BioXtreme's most recent funding round and who were the lead investors?
BioXtreme's most recent funding round was a Grant in March 2024, with Israel Innovation Authority as the lead investor.
Who are the co-founders of BioXtreme?
The co-founders of BioXtreme are Nini Bluman, who serves as CEO, and Haim Hoffman, who serves as CTO.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CTO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingAugmented RealityArtificial IntelligenceMachinery & Robotics
Target customers
Financial ServicesFinancial ProductsInsuranceHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

neurologyimagingroboticsmedical-devicesrehabilitationaugmented-reality3d-technologystrokeartificial-intelligencedigital-healthcareinsurance-companieshealthcare-providersmedical-technologiesoptronicsdigital-therapeuticstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)